A novel design of artificial membrane for improving the PAMPA model

被引:214
作者
Chen, Xiaoxi [1 ]
Murawski, Anthony [1 ]
Patel, Karishma [2 ]
Crespi, Charles L. [1 ]
Balimane, Praveen V. [2 ]
机构
[1] BD Biosci Discovery Labware, Bedford, MA 01730 USA
[2] Bristol Myers Squibb Co, Princeton, NJ 08543 USA
关键词
Caco-2; drug absorption; high throughput screening; parallel artificial membrane permeability assay (PAMPA); permeability;
D O I
10.1007/s11095-007-9517-8
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. Since the first demonstration of PAMPA, the artificial membrane has been traditionally prepared by impregnating a porous filter with a solution of lipid mixture. While the lipid solution-based method is simple and seems to provide good predictability for many compounds, it is challenged by several shortcomings including reproducibility, stability, mass retention and the incorrect prediction of a group of highly permeable compounds including caffeine and antipyrine. Here we present the validation of a novel artificial membrane formed by constructing a lipid/oil/lipid tri-layer in the porous filter. Methods. Permeability values obtained from traditional and new artificial membrane were compared for their correlation with Caco-2 and human absorption values. Mass retention, stability and organic solvent compatibility of the new artificial membrane were studied. Results. The new artificial membrane correctly predicts the permeability of the traditionally under-predicted compounds and improves the correlation with Caco-2 and human absorption values. Furthermore, the new artificial membrane reduces the mass retention of compounds that are highly retained by the traditional artificial membrane. The new artificial membrane is also found to be robust enough to sustain long term storage and has good compatibility with organic solvents. Conclusions. The new artificial membrane provides an improved PAMPA model.
引用
收藏
页码:1511 / 1520
页数:10
相关论文
共 22 条
[1]   Development of a 7-day, 96-well Caco-2 permeability assay with high-throughput direct UV compound analysis [J].
Alsenz, J ;
Haenel, E .
PHARMACEUTICAL RESEARCH, 2003, 20 (12) :1961-1969
[2]   Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond [J].
Artursson, P ;
Borchardt, RT .
PHARMACEUTICAL RESEARCH, 1997, 14 (12) :1655-1658
[3]   PAMPA - A drug absorption in vitro model 13. Chemical selectivity due to membrane hydrogen bonding: In combo comparisons of HDM-, DOPC-, and DS-PAMPA models [J].
Avdeef, A ;
Tsinman, O .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 28 (1-2) :43-50
[4]   Caco-2 permeability of weakly basic drugs predicted with the Double-Sink PAMPA pKaflux method [J].
Avdeef, A ;
Artursson, P ;
Neuhoff, S ;
Lazorova, L ;
Gråsjö, J ;
Tavelin, S .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 24 (04) :333-349
[5]   Drug absorption in vitro model:: filter-immobilized artificial membranes 2.: Studies of the permeability properties of lactones in Piper methysticum Forst [J].
Avdeef, A ;
Strafford, M ;
Block, E ;
Balogh, MP ;
Chambliss, W ;
Khan, I .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 14 (04) :271-280
[6]  
Avdeef A., 2003, ABSORPTION DRUG DEV, DOI [10.1002/047145026X, DOI 10.1002/047145026X]
[7]   PAMPA - Critical factors for better predictions of absorption [J].
Avdeef, Alex ;
Bendels, Stefanie ;
Di, Li ;
Faller, Bernard ;
Kansy, Manfred ;
Sugano, Kiyohiko ;
Yamauchi, Yukinori .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (11) :2893-2909
[8]   Current industrial practices of assessing permeability and P-glycoprotein interaction [J].
Balimane, PV ;
Han, YH ;
Chong, SH .
AAPS JOURNAL, 2006, 8 (01) :E1-E13
[9]   A novel high-throughput automated chip-based nanoelectrospray tandem mass spectrometric method for PAMPA sample analysis [J].
Balimane, PV ;
Pace, E ;
Chong, S ;
Zhu, MS ;
Jemal, M ;
Van Pelt, CK .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 39 (1-2) :8-16
[10]   Cell culture-based models for intestinal permeability: a critique [J].
Balimane, PV ;
Chong, S .
DRUG DISCOVERY TODAY, 2005, 10 (05) :335-343